1. Home
  2. CARE vs FULC Comparison

CARE vs FULC Comparison

Compare CARE & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter Bankshares Inc.

CARE

Carter Bankshares Inc.

HOLD

Current Price

$26.41

Market Cap

507.1M

Sector

Finance

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$6.98

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARE
FULC
Founded
1974
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.1M
467.8M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
CARE
FULC
Price
$26.41
$6.98
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
$25.00
$16.38
AVG Volume (30 Days)
311.5K
677.6K
Earning Date
04-23-2026
04-27-2026
Dividend Yield
0.40%
N/A
EPS Growth
30.19
N/A
EPS
3.88
N/A
Revenue
$20,315,000.00
N/A
Revenue This Year
$12.50
N/A
Revenue Next Year
$11.82
N/A
P/E Ratio
$19.00
N/A
Revenue Growth
4.65
N/A
52 Week Low
$15.48
$5.47
52 Week High
$26.58
$15.74

Technical Indicators

Market Signals
Indicator
CARE
FULC
Relative Strength Index (RSI) 76.40 40.99
Support Level $19.34 $6.39
Resistance Level N/A $7.09
Average True Range (ATR) 0.68 0.47
MACD 0.06 -0.06
Stochastic Oscillator 92.51 10.81

Price Performance

Historical Comparison
CARE
FULC

About CARE Carter Bankshares Inc.

Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

Share on Social Networks: